Browse > Article
http://dx.doi.org/10.4110/in.2011.11.3.135

MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease  

Ha, Tai-You (Department of Immunology, Chonbuk National University Medical School)
Publication Information
IMMUNE NETWORK / v.11, no.3, 2011 , pp. 135-154 More about this Journal
Abstract
The great discovery of microRNAs (miRNAs) has revolutionized current cell biology and medical science. miRNAs are small conserved non-coding RNA molecules that post-transcriptionally regulate gene expression by targeting the 3' untranslated region of specific messenger RNAs for degradation or translational repression. New members of the miRNA family are being discovered on a daily basis and emerging evidence has demonstrated that miRNAs play a major role in a wide range of developmental process including cell proliferation, cell cycle, cell differentiation, metabolism, apoptosis, developmental timing, neuronal cell fate, neuronal gene expression, brain morphogenesis, muscle differentiation and stem cell division. Moreover, a large number of studies have reported links between alterations of miRNA homeostasis and pathological conditions such as cancer, psychiatric and neurological diseases, cardiovascular disease, and autoimmune disease. Interestingly, in addition, miRNA deficiencies or excesses have been correlated with a number of clinically important diseases ranging from cancer to myocardial infarction. miRNAs can repress the gene translation of hundreds of their targets and are therefore well-positioned to target a multitude of cellular mechanisms. As a consequence of extensive participation in normal functions, it is quite logical to ask the question if abnormalities in miRNAs should have importance in human diseases. Great discoveries and rapid progress in the past few years on miRNAs provide the hope that miRNAs will in the near future have a great potential in the diagnosis and treatment of many diseases. Currently, an explosive literature has focussed on the role of miRNA in human cancer and cardiovascular disease. In this review, I briefly summarize the explosive current studies about involvement of miRNA in various human cancers and cardiovascular disease.
Keywords
MicroRNAs; Human disease; Cancer; Heart disease;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Abdellatif M: The role of microRNA-133 in cardiac hypertrophy uncovered. Circ Res 106;16-18, 2010   DOI   ScienceOn
2 Kim VN, Han J, Siomi MC: Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10;126-139, 2009   DOI   ScienceOn
3 Kim VN: Small RNAs: classification, biogenesis, and function. Mol Cells 19;1-15, 2005   DOI   ScienceOn
4 Boyd SD: Everything you wanted to know about small RNA but were afraid to ask. Lab Invest 88;569-578, 2008   DOI   ScienceOn
5 Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A: Identification of mammalian microRNA host genes and transcription units. Genome Res 14;1902-1910, 2004   DOI   ScienceOn
6 Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103;2257-2261, 2006   DOI   ScienceOn
7 Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT: Altered microRNA expression in human heart disease. Physiol Genomics 31;367-373, 2007   DOI   ScienceOn
8 Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N: Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55;1944-1949, 2009   DOI   ScienceOn
9 Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105;10513-10518, 2008   DOI   ScienceOn
10 Latronico MV, Catalucci D, Condorelli G: Emerging role of microRNAs in cardiovascular biology. Circ Res 101; 1225-1236, 2007   DOI   ScienceOn
11 van Rooij E, Marshall WS, Olson EN: Toward microRNAbased therapeutics for heart disease: the sense in antisense. Circ Res 103;919-928, 2008   DOI   ScienceOn
12 Witwer KW, Sisk JM, Gama L, Clements JE: MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response. J Immunol 184;2369-2376, 2010   DOI   ScienceOn
13 Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J: Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res 108;305-313, 2011   DOI   ScienceOn
14 Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Cote J, Simard MJ, Bonnet S: Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208;535-548, 2011   DOI   ScienceOn
15 Mattes J, Collison A, Plank M, Phipps S, Foster PS: Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A 106;18704-18709, 2009   DOI   ScienceOn
16 Polikepahad S, Knight JM, Naghavi AO, Oplt T, Creighton CJ, Shaw C, Benham AL, Kim J, Soibam B, Harris RA, Coarfa C, Zariff A, Milosavljevic A, Batts LM, Kheradmand F, Gunaratne PH, Corry DB: Proinflammatory role for let-7 microRNAS in experimental asthma. J Biol Chem 285; 30139-30149, 2010   DOI
17 Li Y, Chan EY, Li J, Ni C, Peng X, Rosenzweig E, Tumpey TM, Katze MG: MicroRNA expression and virulence in pandemic influenza virus-infected mice. J Virol 84;3023- 3032, 2010   DOI   ScienceOn
18 Pandey AK, Agarwal P, Kaur K, Datta M: MicroRNAs in diabetes: tiny players in big disease. Cell Physiol Biochem 23;221-232, 2009   DOI   ScienceOn
19 Fulci V, Scappucci G, Sebastiani GD, Giannitti C, Franceschini D, Meloni F, Colombo T, Citarella F, Barnaba V, Minisola G, Galeazzi M, Macino G: miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol 71;206-211, 2010   DOI   ScienceOn
20 Buckner JH: Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10;849-859, 2010   DOI   ScienceOn
21 Sonkoly E, Pivarcsi A: Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med 13;24-38, 2009
22 Yi R, Fuchs E: MicroRNA-mediated control in the skin. Cell Death Differ 17;229-235, 2010   DOI   ScienceOn
23 Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA: The role of microRNA-146a (miR-146a) and its target IL- 1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol 71;382-385, 2010   DOI   ScienceOn
24 Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D: miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med 208;549-560, 2011   DOI   ScienceOn
25 Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N, McGlinn E, Heiser PW, Wills AM, Wirguin I, Rubin LL, Misawa H, Tabin CJ, Brown R Jr, Chen A, Hornstein E: miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A 107;13111-13116, 2010   DOI   ScienceOn
26 De Santis G, Ferracin M, Biondani A, Caniatti L, Rosaria Tola M, Castellazzi M, Zagatti B, Battistini L, Borsellino G, Fainardi E, Gavioli R, Negrini M, Furlan R, Granieri E: Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 226;165-171, 2010   DOI   ScienceOn
27 Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ, Tran N, Dedova I, Cairns MJ: Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 17;1156-1168, 2008   DOI   ScienceOn
28 Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT: The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28;1213-1223, 2008   DOI   ScienceOn
29 Tili E, Michaille JJ, Costinean S, Croce CM: MicroRNAs, the immune system and rheumatic disease. Nat Clin Pract Rheumatol 4;534-541, 2008
30 Leeper NJ, Cooke JP: MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitus. Circulation 123; 236-238, 2011   DOI   ScienceOn
31 Germain RN, Meier-Schellersheim M, Nita-Lazar A, Fraser ID: Systems biology in immunology: a computational modeling perspective. Annu Rev Immunol 29;527-585, 2011   DOI   ScienceOn
32 Lu LF, Liston A: MicroRNA in the immune system, microRNA as an immune system. Immunology 127;291- 298, 2009   DOI   ScienceOn
33 Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17;211-215, 2011   DOI   ScienceOn
34 Liston A, Linterman M, Lu LF: MicroRNA in the adaptive immune system, in sickness and in health. J Clin Immunol 30;339-346, 2010   DOI   ScienceOn
35 Schetter AJ, Heegaard NH, Harris CC: Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31;37-49, 2010   DOI   ScienceOn
36 Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP, Pestell RG: microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A 107;8231-8236, 2010   DOI   ScienceOn
37 Navarro A, Gaya A, Martinez A, Urbano-Ispizua A, Pons A, Balague O, Gel B, Abrisqueta P, Lopez-Guillermo A, Artells R, Montserrat E, Monzo M: MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 111;2825- 2832, 2008   DOI   ScienceOn
38 Contu R, Latronico MV, Condorelli G: Circulating micro- RNAs as potential biomarkers of coronary artery disease: a promise to be fulfilled? Circ Res 107;573-574, 2010   DOI   ScienceOn
39 Hernando E: microRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol 9;155-160, 2007   DOI   ScienceOn
40 Osaki M, Takeshita F, Ochiya T: MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13; 658-670, 2008   DOI   ScienceOn
41 Saini S, Majid S, Dahiya R: Diet, microRNAs and prostate cancer. Pharm Res 27;1014-1026, 2010   DOI   ScienceOn
42 Gebeshuber CA, Zatloukal K, Martinez J: miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10;400-405, 2009   DOI   ScienceOn
43 Hunsberger JG, Austin DR, Chen G, Manji HK: MicroRNAs in mental health: from biological underpinnings to potential therapies. Neuromolecular Med 11;173-182, 2009   DOI   ScienceOn
44 Baccarelli A, Bollati V: Epigenetics and environmental chemicals. Curr Opin Pediatr 21;243-251, 2009   DOI   ScienceOn
45 Marsit CJ, Eddy K, Kelsey KT: MicroRNA responses to cellular stress. Cancer Res 66;10843-10848, 2006   DOI   ScienceOn
46 Shin S, Cha HJ, Lee EM, Lee SJ, Seo SK, Jin HO, Park IC, Jin YW, An S: Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Int J Oncol 35;81-86, 2009
47 Lovis P, Roggli E, Laybutt DR, Gattesco S, Yang JY, Widmann C, Abderrahmani A, Regazzi R: Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 57;2728-2736, 2008   DOI   ScienceOn
48 Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6;857-866, 2006   DOI   ScienceOn
49 Slezak-Prochazka I, Durmus S, Kroesen BJ, van den Berg A: MicroRNAs, macrocontrol: regulation of miRNA processing. RNA 16;1087-1095, 2010   DOI   ScienceOn
50 Shenouda SK, Alahari SK: MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28;369-378, 2009   DOI   ScienceOn
51 Ambros V: The functions of animal microRNAs. Nature 431;350-355, 2004   DOI   ScienceOn
52 Hwang HW, Mendell JT: MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94;776-780, 2006   DOI   ScienceOn
53 Alvarez-Garcia I, Miska EA: MicroRNA functions in animal development and human disease. Development 132;4653- 4662, 2005   DOI   ScienceOn
54 Di Leva G, Calin GA, Croce CM: MicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Res C Embryo Today 78;180-189, 2006   DOI   ScienceOn
55 Garzon R, Marcucci G, Croce CM: Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 9;775-789, 2010   DOI   ScienceOn
56 Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 144;646-674, 2011   DOI   ScienceOn
57 Soifer HS, Rossi JJ, Saetrom P: MicroRNAs in disease and potential therapeutic applications. Mol Ther 15;2070-2079, 2007   DOI   ScienceOn
58 Lynam-Lennon N, Maher SG, Reynolds JV: The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 84;55-71, 2009   DOI   ScienceOn
59 Zhang B, Pan X, Cobb GP, Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302;1-12, 2007   DOI   ScienceOn
60 Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q: Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31;659-666, 2010   DOI   ScienceOn
61 Miller BH, Wahlestedt C: MicroRNA dysregulation in psychiatric disease. Brain Res 1338;89-99, 2010   DOI
62 Belver L, de Yebenes VG, Ramiro AR: MicroRNAs prevent the generation of autoreactive antibodies. Immunity 33; 713-722, 2010   DOI   ScienceOn
63 Guo H, Ingolia NT, Weissman JS, Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466;835-840, 2010   DOI   ScienceOn
64 Maes OC, Chertkow HM, Wang E, Schipper HM: Micro- RNA: Implications for Alzheimer Disease and other Human CNS Disorders. Curr Genomics 10;154-168, 2009   DOI   ScienceOn
65 Tili E, Michaille JJ, Calin GA: Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci 5;73-79, 2008
66 Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Ménard S, Croce CM: MicroRNA signatures in human ovarian cancer. Cancer Res 67;8699-8707, 2007   DOI   ScienceOn
67 Perera RJ, Ray A: MicroRNAs in the search for understanding human diseases. BioDrugs 21;97-104, 2007   DOI   ScienceOn
68 Ha TY: The Role of MicroRNAs in Regulatory T Cells and in the Immune Response. Immune Netw 11;11-41, 2011   DOI
69 Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q: An analysis of human microRNA and disease associations. PLoS One 3;e3420, 2008
70 Garofalo M, Condorelli G, Croce CM: MicroRNAs in diseases and drug response. Curr Opin Pharmacol 8;661-667, 2008   DOI   ScienceOn
71 Melkamu T, Zhang X, Tan J, Zeng Y, Kassie F: Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol. Carcinogenesis 31; 252-258, 2010   DOI   ScienceOn
72 Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman- Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D, Ober C: Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 81;829- 834, 2007   DOI   ScienceOn
73 Caporali A, Meloni M, Vollenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH, Agami R, le Sage C, Condorelli G, Madeddu P, Martelli F, Emanueli C: Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 123;282-291, 2011   DOI   ScienceOn
74 Tomankova T, Petrek M, Kriegova E: Involvement of microRNAs in physiological and pathological processes in the lung. Respir Res 11;159, 2010   DOI   ScienceOn
75 Pallante P, Visone R, Croce CM, Fusco A: Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer 17;F91-F104, 2010   DOI   ScienceOn
76 Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N: Widespread changes in protein synthesis induced by microRNAs. Nature 455;58-63, 2008   DOI   ScienceOn
77 Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP: The impact of microRNAs on protein output. Nature 455;64-71, 2008   DOI   ScienceOn
78 Gueta K, Molotski N, Gerchikov N, Mor E, Savion S, Fein A, Toder V, Shomron N, Torchinsky A: Teratogen-induced alterations in microRNA-34, microRNA-125b and micro- RNA-155 expression: correlation with embryonic p53 genotype and limb phenotype. BMC Dev Biol 10;20, 2010   DOI
79 Yang N, Coukos G, Zhang L: MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment. Int J Cancer 122;963-968, 2008
80 Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC: Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 66;1277-1281, 2006   DOI   ScienceOn
81 Nelson PT, Wang WX, Rajeev BW: MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol 18;130-138, 2008   DOI   ScienceOn
82 Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10;704-714, 2009   DOI   ScienceOn
83 Ha TY: The role of regulatory T cells in cancer. Immune Netw 9;209-235, 2009   DOI
84 Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY: Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205;1993-2004, 2008   DOI   ScienceOn
85 Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M, Li X, Tang H: MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1. FEBS J 276;5537-5546, 2009   DOI   ScienceOn
86 Taylor DD, Gercel-Taylor C: MicroRNA signatures of tumor- derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110;13-21, 2008   DOI   ScienceOn
87 Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R: The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14;1271- 1277, 2008   DOI   ScienceOn
88 Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT, Bluestone JA: Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205;1983-1991, 2008   DOI   ScienceOn
89 Cobb BS, Hertweck A, Smith J, O'Connor E, Graf D, Cook T, Smale ST, Sakaguchi S, Livesey FJ, Fisher AG, Merkenschlager M: A role for Dicer in immune regulation. J Exp Med 203;2519-2527, 2006   DOI   ScienceOn
90 Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM: Modulation of miR-155 and miR-125b levels following lipopolysaccharide/ TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179;5082-5089, 2007   DOI
91 Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65;7065-7070, 2005   DOI   ScienceOn
92 Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353;1793-1801, 2005   DOI   ScienceOn
93 Zaman MS, Chen Y, Deng G, Shahryari V, Suh SO, Saini S, Majid S, Liu J, Khatri G, Tanaka Y, Dahiya R: The functional significance of microRNA-145 in prostate cancer. Br J Cancer 103;256-264, 2010   DOI   ScienceOn
94 Ventura A, Jacks T: MicroRNAs and cancer: short RNAs go a long way. Cell 136;586-591, 2009   DOI   ScienceOn
95 Jazbutyte V, Thum T: MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 11;926-935, 2010   DOI   ScienceOn
96 Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD: Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120;1046-1054, 2007
97 Waldman SA, Terzic A: Applications of microRNA in cancer: Exploring the advantages of miRNA. Clin Transl Sci 2;248-249, 2009   DOI   ScienceOn
98 Waldman SA, Terzic A: A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer. FEBS J 276;2157-2164, 2009   DOI   ScienceOn
99 Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J: Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451;147-152, 2008   DOI   ScienceOn
100 Slaby O, Svoboda M, Michalek J, Vyzula R: MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 8;102, 2009   DOI
101 Small EM, Olson EN: Pervasive roles of microRNAs in cardiovascular biology. Nature 469;336-342, 2011   DOI   ScienceOn
102 Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207;243-249, 2005   DOI   ScienceOn
103 Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B: Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 105;3945-3950, 2008   DOI   ScienceOn
104 Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101;2999-3004, 2004   DOI   ScienceOn
105 Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K: MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 113;396-402, 2009
106 Bullrich F, Fujii H, Calin G, Mabuchi H, Negrini M, Pekarsky Y, Rassenti L, Alder H, Reed JC, Keating MJ, Kipps TJ, Croce CM: Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 61; 6640-6648, 2001
107 Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE: MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93;1600-1608, 2008   DOI   ScienceOn
108 Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM: MicroRNA 29b functions in acute myeloid leukemia. Blood 114;5331-5341, 2009   DOI   ScienceOn
109 Mantovani A, Romero P, Palucka AK, Marincola FM: Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 371;771-783, 2008   DOI   ScienceOn
110 Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137;1005-1017, 2009   DOI   ScienceOn
111 Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS, Sung JJ: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58;1375-1381, 2009   DOI   ScienceOn
112 Tan W, Zhang W, Strasner A, Grivennikov S, Cheng JQ, Hoffman RM, Karin M: Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 470;548-553, 2011   DOI   ScienceOn
113 Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, Goggins MG, Mendell JT, Maitra A: Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9;293-301, 2009   DOI   ScienceOn
114 Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA: MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26;4442-4452, 2007   DOI   ScienceOn
115 Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C: Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg 33;698-709, 2009   DOI   ScienceOn
116 Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T: Epigenetic silencing of microRNA- 34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68;4123-4132, 2008   DOI   ScienceOn
117 Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, Chen HY, Sun XF: Clinicopathological significance of microRNA- 31, -143 and -145 expression in colorectal cancer. Dis Markers 26;27-34, 2009   DOI
118 Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127;118-126, 2010   DOI   ScienceOn
119 Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD: MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9;839-845, 2008   DOI   ScienceOn
120 Nishida N, Yokobori T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Kuwano H, Mori M: MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int J Oncol 38;1437-1443, 2011
121 Negrini M, Nicoloso MS, Calin GA: MicroRNAs and cancer-- new paradigms in molecular oncology. Curr Opin Cell Biol 21;470-479, 2009   DOI   ScienceOn
122 Wang QZ, Xu W, Habib N, Xu R: Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets 9;572-594, 2009   DOI   ScienceOn
123 Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E: Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer 10;318, 2010   DOI
124 Liu X, Wang T, Wakita T, Yang W: Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology 398;57-67, 2010   DOI   ScienceOn
125 Lee YS, Dutta A: MicroRNAs in cancer. Annu Rev Pathol 4;199-227, 2009   DOI   ScienceOn
126 Saito Y, Suzuki H, Hibi T: The role of microRNAs in gastrointestinal cancers. J Gastroenterol 44(Suppl 19);18-22, 2009   DOI
127 Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni L, Zhang WG, Nan KJ, Song TS, Huang C: MicroRNA profiling of human gastric cancer. Mol Med Report 2;963-970, 2009
128 O'Neill LA, Sheedy FJ, McCoy CE: MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 11;163-175, 2011   DOI   ScienceOn
129 O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D: Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10;111-122, 2010   DOI   ScienceOn
130 Belair C, Darfeuille F, Staedel C: Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship. Clin Microbiol Infect 15;806-812, 2009   DOI   ScienceOn
131 Small EM, Frost RJ, Olson EN: MicroRNAs add a new dimension to cardiovascular disease. Circulation 121;1022-1032, 2010   DOI   ScienceOn
132 Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H: Suppression of hepatitis B virus replication by microRNA- 199a-3p and microRNA-210. Antiviral Res 88;169-175, 2010   DOI   ScienceOn
133 Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116;281-297, 2004   DOI   ScienceOn
134 Winter J, Jung S, Keller S, Gregory RI, Diederichs S: Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11;228-234, 2009   DOI   ScienceOn
135 Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S: Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49;1098-1112, 2009   DOI   ScienceOn
136 Zhao H, Wang D, Du W, Gu D, Yang R: MicroRNA and leukemia: tiny molecule, great function. Crit Rev Oncol Hematol 74;149-155, 2010   DOI   ScienceOn
137 Barringhaus KG, Zamore PD: MicroRNAs: regulating a change of heart. Circulation 119;2217-2224, 2009   DOI   ScienceOn
138 Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B: Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3;499-506, 2010   DOI
139 Chu CY, Rana TM: Small RNAs: regulators and guardians of the genome. J Cell Physiol 213;412-419, 2007   DOI   ScienceOn
140 Latronico MV, Condorelli G: MicroRNAs and cardiac pathology. Nat Rev Cardiol 6;419-429, 2009
141 Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller- Ardogan M, Bonauer A, Zeiher AM, Dimmeler S: Circulating microRNAs in patients with coronary artery disease. Circ Res 107;677-684, 2010   DOI   ScienceOn